SciVision Biotech Inc.

TWSE:1786 Voorraadrapport

Marktkapitalisatie: NT$6.5b

SciVision Biotech Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

SciVision Biotech heeft een totaal eigen vermogen van NT$1.8B en een totale schuld van NT$137.0M, wat de schuld-eigenvermogensverhouding op 7.5% brengt. De totale activa en totale passiva bedragen respectievelijk NT$2.1B en NT$321.6M. De EBIT SciVision Biotech is NT$249.1M waardoor de rentedekking -18.4 is. Het heeft contanten en kortetermijnbeleggingen van NT$718.7M.

Belangrijke informatie

7.5%

Verhouding schuld/eigen vermogen

NT$137.00m

Schuld

Rente dekkingsratio-18.4x
ContantNT$718.71m
AandelenNT$1.82b
Totaal verplichtingenNT$321.64m
Totaal activaNT$2.15b

Recente financiële gezondheidsupdates

Recent updates

Is Now The Time To Put SciVision Biotech (TWSE:1786) On Your Watchlist?

Oct 11
Is Now The Time To Put SciVision Biotech (TWSE:1786) On Your Watchlist?

SciVision Biotech Inc.'s (TWSE:1786) 27% Price Boost Is Out Of Tune With Earnings

Aug 30
SciVision Biotech Inc.'s (TWSE:1786) 27% Price Boost Is Out Of Tune With Earnings

SciVision Biotech's (TWSE:1786) Upcoming Dividend Will Be Larger Than Last Year's

Jul 22
SciVision Biotech's (TWSE:1786) Upcoming Dividend Will Be Larger Than Last Year's

SciVision Biotech (TWSE:1786) Has Announced That It Will Be Increasing Its Dividend To NT$2.50

Jun 28
SciVision Biotech (TWSE:1786) Has Announced That It Will Be Increasing Its Dividend To NT$2.50

SciVision Biotech Inc.'s (TWSE:1786) 27% Price Boost Is Out Of Tune With Earnings

Jun 14
SciVision Biotech Inc.'s (TWSE:1786) 27% Price Boost Is Out Of Tune With Earnings

SciVision Biotech (TWSE:1786) Seems To Use Debt Rather Sparingly

Jun 04
SciVision Biotech (TWSE:1786) Seems To Use Debt Rather Sparingly

Some Shareholders Feeling Restless Over SciVision Biotech Inc.'s (TWSE:1786) P/E Ratio

Apr 01
Some Shareholders Feeling Restless Over SciVision Biotech Inc.'s (TWSE:1786) P/E Ratio

Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly

Apr 20
Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly

SciVision Biotech (TPE:1786) Is Looking To Continue Growing Its Returns On Capital

Apr 02
SciVision Biotech (TPE:1786) Is Looking To Continue Growing Its Returns On Capital

Can You Imagine How SciVision Biotech's (TPE:1786) Shareholders Feel About The 33% Share Price Increase?

Mar 15
Can You Imagine How SciVision Biotech's (TPE:1786) Shareholders Feel About The 33% Share Price Increase?

Read This Before Buying SciVision Biotech Inc. (TPE:1786) For Its Dividend

Feb 25
Read This Before Buying SciVision Biotech Inc. (TPE:1786) For Its Dividend

Could The Market Be Wrong About SciVision Biotech Inc. (TPE:1786) Given Its Attractive Financial Prospects?

Feb 05
Could The Market Be Wrong About SciVision Biotech Inc. (TPE:1786) Given Its Attractive Financial Prospects?

Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly

Jan 18
Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly

Will The ROCE Trend At SciVision Biotech (TPE:1786) Continue?

Jan 01
Will The ROCE Trend At SciVision Biotech (TPE:1786) Continue?

SciVision Biotech (TPE:1786) Shareholders Booked A 80% Gain In The Last Three Years

Dec 14
SciVision Biotech (TPE:1786) Shareholders Booked A 80% Gain In The Last Three Years

Key Things To Consider Before Buying SciVision Biotech Inc. (TPE:1786) For Its Dividend

Nov 25
Key Things To Consider Before Buying SciVision Biotech Inc. (TPE:1786) For Its Dividend

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( NT$1.0B ) 1786 } overtreffen de korte termijn passiva ( NT$123.4M ).

Langlopende schulden: De kortetermijnactiva 1786 ( NT$1.0B ) overtreffen de langetermijnschulden ( NT$198.2M ).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 1786 heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van 1786 is de afgelopen 5 jaar gedaald van 21.8% naar 7.5%.

Schuldendekking: De schuld van 1786 wordt goed gedekt door de operationele kasstroom ( 183% ).

Rentedekking: 1786 verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.


Balans


Ontdek gezonde bedrijven